Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas. (6th October 2021)

• Record Type: Journal Article
• Authors: Jin, Xing; Zheng, Yuansheng; Chen, Zhencong; Wang, Fei; Bi, Guoshu; Li, Ming; Liang, Jiaqi; Sui, Qihai; Bian, Yunyi; Hu, Zhengyang; Qiao, Yulei; Xu, Songtao
• Is Part Of: Cancer medicine. Volume 10:Number 23(2021)
• Page Start: 8673
• Page End: 8692
• Publication Date: 2021-10-06
• Subjects: cullin 3 (CUL3) -- kelch‐like ECH‐associated protein 1 (KEAP1) -- lung adenocarcinoma (LUAD) -- mutation -- nuclear factor erythroid 2‐like 2 (NFE2L2); 616.994005
• DOI: 10.1002/cam4.4338
• Languages: English
• ISSNs: 2045-7634

Abstract

Abstract: Objectives: To explore the clinical features, molecular characteristics, and immune landscape of lung adenocarcinoma patients with KEAP1/NFE2L2/CUL3 mutations. Methods: The multi‐omics data from the GDC‐TCGA LUAD project of The Cancer Genome Atlas (TCGA) database were downloaded from the Xena browser. The estimate of the immune infiltration was implemented by using the GSVA analysis and CIBERSORT. The status of KEAP1/NFE2L2/CUL3 mutation in 50 LUAD samples of our department was detected by using Sanger sequencing, following the relative expression level of differentially expressed genes (DEGs), miRNAs (DEmiRNAs), and lncRNAs (DElncRNAs) was validated by IHC and real‐time quantitative polymerase chain reaction (RT‐qPCR). Results: The Kaplan–Meier and multivariable Cox regression analyses demonstrated that KEAP1/NFE2L2/CUL3 mutations had independent prognostic value for OS and PFS in LUAD patients. The differential analysis detected 207 upregulated genes (like GSR/UGT1A6) and 447 downregulated genes (such as PIGR). GO, KEGG, and GSEA analyses demonstrated that DEGs were enriched in glutamate metabolism and the immune response. The constructed ceRNA network shows the linkage of differential lncRNAs and mRNAs. Three hundred and nine somatic mutations were detected, alterations in immune infiltration DNA methylations and stemness scores were also founded between the two groups. Eight mutated LUAD patients were detected by Sanger DNA sequencing in 50 surgical patients. GSR and UGT1A6 were validated to express higher in the Mut group, whereas the expression of PIGR was restrained. Furthermore, the IHC staining conducted on paraffin‐embedded tissue emphasizes the consistency of our result. Conclusion: This research implemented the comprehensive analysis of KEAP1/NFE2L2/CUL3 somatic mutations in the LUAD patients. Compared with the wild type of LUAD patients, the Mut group shows a large difference in clinical features, RNA sequence, DNA methylation, and immune infiltrations, indicating complex mechanism oncogenesis and also reveals potential therapeutic targets. Abstract : For the first time, an integrated multi‐mics analysis of KEAP1/NFE2L2/CUL3 mutated LUAD patients was performed. Based on several independent database, we validated the clinical value of KEAP1/NFE2L2/CUL3 in univiarate and multiviarate analyses. Our research shed light on the significance of potential therapeutical target via bioinformatics analyses and experimental verification.